Publication

Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

Dumoulin, D., de Goeje, P., Poncin, M., Bezemer, K., Groen, H. J. M., Smit, E. F., Dingemans, A-M. C., Kunert, A., Hendriks, R. & Aerts, J. G., Apr-2019, In : Annals of Oncology. 30 , Suppl 2, p. ii7 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

Copy link to clipboard

Documents

  • Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

    Final publisher's version, 97 KB, PDF document

    Request copy

DOI

  • D Dumoulin
  • P de Goeje
  • M Poncin
  • K Bezemer
  • H J M Groen
  • E F Smit
  • A-M C Dingemans
  • A Kunert
  • R Hendriks
  • J G Aerts
Original languageEnglish
Pages (from-to)ii7
Number of pages1
JournalAnnals of Oncology
Volume30
Issue numberSuppl 2
Publication statusPublished - Apr-2019
EventEuropean Lung Cancer Congress (ELCC) - Geneva, Switzerland
Duration: 10-Apr-201913-Apr-2019

Event

European Lung Cancer Congress (ELCC)

10/04/201913/04/2019

Geneva, Switzerland

Event: Conference

ID: 120124478